Triochem Products has informed that the meeting of the Board of Directors of the Company is scheduled on 12/02/2021, to consider and approve the Un-audited Financial Results of the Company for the Quarter and Nine months ended 31st December 2020; and any other business with the permission of the chair. In continuation to letter no- Ref No: TPL PP 201203 2020; 31st December 2020 for the aforesaid purpose, the closure of trading window has been closed from 1st January, 2021 which will continue to remain closed tin 48hours after the declaration of Financial Results of the Company as per the Company's ‘Code of Conduct for Prevention of Insider Trading and Code of Fair Disclosure of Unpublished Price Sensitive Information’ for all the Designated Persons of the Company (including their immediate Relatives). The notice is also available on the website of the Company at www.triochemproducts.com
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1619.95 |
| Dr. Reddys Lab | 1315.85 |
| Cipla | 1294.75 |
| Zydus Lifesciences | 927.15 |
| Lupin | 2296.10 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: